Navigation Links
Discovery of new type of immune cells regulating inflammation in chronic diseases
Date:11/20/2009

This release is available in German.

In the current online issue of the Journal of Clinical Investigation, Dr. Stefanie Eyerich and Dr. Kilian Eyerich together with their colleagues from Imperial College London and Istituto Dermopatico dell'Immacolata in Rome, present their groundbreaking discovery. It represents a milestone on the way to developing new treatment methods for inflammatory skin diseases such as psoriasis and allergic reactions and potentially also allergic respiratory diseases such as asthma.

The newly discovered Th22 cells are a previously unknown subset of T helper cells. T helper cells are white blood cells that help activate other immune cells when the body is infected by viruses or bacteria. At the same time they help the body to tolerate own tissue and to prevent or curb inflammation.

The researchers of Helmholtz Zentrum Mnchen and the Center of Allergy and Environment (ZAUM) of Technische Universitt Mnchen, together with their colleagues from London and Rome, discovered the Th22 cells while analyzing skin samples of patients with psoriasis, atopic eczema and allergic contact dermatitis. "During the histological examination we noticed T cells that were primarily characterized by the signaling molecule interleukin-22 (IL-22)," explained Dr. Stefanie Eyerich, the lead author of the study.

Th22 cells aid in tissue repair. At the same time they warn our skin cells of impending environmental dangers and stimulate the skin cells to protect themselves. In addition, they can help to strengthen the barriers of the skin and possibly also of the lung by stimulating cells to produce more collagen.

Dr. Carsten Schmidt-Weber of Imperial College London and coordinator of the study said: "We are seeing an increase in chronic diseases like skin and respiratory diseases. Besides genetic disposition, the causes are higher hygienic standards and modern nutritional habits. Diseases like psoriasis can have a substantial negative impact on a patient's quality of life, and sufferers must often follow long, drawn-out skin care treatment regimens to keep their symptoms at bay."

"We consider the discovery of the Th22 cells to be a milestone in immunology, providing a new starting point for the future treatment of chronic inflammatory diseases such as eczema, scleroderma, asthma or COPD," explained Professor Heidrun Behrendt, director of ZAUM and the Clinical Cooperation Group of Helmholtz Zentrum Mnchen and TU Mnchen.

The Munich researchers and their colleagues are elucidating the genesis of Th22 cells and investigating Th22-specific genes, which shall contribute to the development of selective and effective therapies for patients with chronic skin and respiratory diseases. Like other T helper cells, Th22 cells belong to a part of the immune system which can recognize damaging pathogens even after a long time has passed. This means that each treatment targeting these cells would have a potential long-term effect.


'/>"/>

Contact: Sven Winkler
presse@helmholtz-muenchen.de
49-089-318-73946
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related biology news :

1. Accidental discovery produces durable new blue pigment for multiple applications
2. NJIT professor to speak about discovery to Physical Society
3. Fish vision discovery makes waves in natural selection
4. Graffinity Enters into Drug Discovery Research Collaboration with Genentech
5. Milestone discovery in cell behaviors
6. Major discovery opens door to leishmania treatment
7. Genetic discovery could break wine industry bottleneck, accelerate grapevine breeding
8. UCF discovery could open door to obesity, diabetes treatments
9. Gene discovery reveals a critical proteins function in hearing
10. Discovery of genetic mutation in Leigh syndrome
11. Discovery to aid in future treatments of third-world parasites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):
(Date:8/21/2017)... Linda, Ca (PRWEB) , ... August 21, 2017 ... ... has arranged for two speakers for this two-part educational webinar, in which attendees ... complex subunit, and associated protein factor composition. Along with an overview of the ...
(Date:8/18/2017)... ... August 18, 2017 , ... Producers ... feature Federal Hybrids, Inc. in an upcoming episode, scheduled to broadcast fourth quarter ... will explore Federal Hybrids, the independent, family-owned seed company. Educating audiences about its ...
(Date:8/17/2017)... Springs, FL (PRWEB) , ... August 17, 2017 ... ... announced that the stock market news outlet had provided a research update on ... company's nasally administered TRT product. , According to Soulstring, prescription rates for Natesto® ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Tunnell ... part in sessions at the ISPE Annual Meeting and Expo , to be ... Diego Marina. The event’s theme is “Driving innovation to advance patient therapies.” , The ...
Breaking Biology Technology: